Papatheodoridis, M. Rigopoulou, E. Hadziyannis, E. Kalliopi, Z. Xourafas, V. Lyberopoulou, A. Gatselis, N. and Vlachogiannakos, I. Manolakopoulos, S. Dalekos, G. and Papatheodoridis, G., Rates and predictors of HBsAg loss after discontinuation of effective
long-term Entecavir or Tenofovir therapy in non-cirrhotic HBeAg-negative
chronic hepatitis B patients: Results from the DARING-B prospective
Greek study, WORLD JOURNAL OF HEPATOLOGY, (68), S88-S89, 2018, ELSEVIER SCIENCE BV,